Source: Eur Respir J, 49 (5) 1700054; 10.1183/13993003.00054-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yingmeng Ni, Guochao Shi. Phenotypes contribute to treatments. Eur Respir J, 49 (5) 1700054; 10.1183/13993003.00054-2017

Member's Comments

No comment yet.

Related content which might interest you: Phenotypes and endotypes Source: Eur Respir Monogr 2018; 81: 133-152 Year: 2018 Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Factors that affect the treatment of patients with asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Phenotypes and prognosis Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment Year: 2019 Associations between genetic polymorphisms and drug response phenotypes in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Underlying mechanisms and pharmacological approaches for treatment of sarcopenia Source: Virtual Congress 2021 – Sarcopenia in chronic respiratory disease: new definitions, assessment and treatment options Year: 2021 Physiological phenotypes Source: Eur Respir Monogr 2015; 67: 9-23 Year: 2015 Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Genetic and environmental influences on different asthma phenotypes Source: Eur Respir J 2002; 20: Suppl. 38, 426s Year: 2002 When and how to identify resistance mechanisms to targeted therapies Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Phenotypes in difficult to treat asthma Source: Annual Congress 2009 - Phenotype-driven asthma treatment in children Year: 2009 COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation? Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Features of FeNO-high asthma phenotype Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Markers of cell proliferation contributes to the therapeutic effect of growth factor-LGF on experimental emphysema Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Rare genetic variants in genes with ciliary function underlie non-smoking related COPD Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Polymorphisms in CCR5 confer susceptibility to Löfgren‘s syndrome and may regulate the immune response Source: Annual Congress 2011 - Biomarkers in sarcoidosis Year: 2011